Compared Unidirectional Valve Apparatus and Occluding the Non-ventilated Endobronchial Lumen for Lung Collapse.
NCT ID: NCT06210256
Last Updated: 2024-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
192 participants
INTERVENTIONAL
2024-01-25
2024-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Disconnection Technique With a Bronchial Blocker for Improving Lung Deflation
NCT01846936
Comparing Valve-regulated Pleural Drainage to Traditional Closed Chest Tube Drainage
NCT06410716
The Effect of a Combined Drainage Strategy in Uniportal Upper Lung Lobectomy
NCT04461652
Techniques for Lung Deflation With Arndt® Blocker
NCT02030795
Clinical Trial of Thoracoscopic Lobecotmy Under Spontaneous Ventilating Anesthesia
NCT03432637
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After patients entered the operating room, their heart rate, mean arterial pressure, electrocardiogram, and pulse oxygen saturation were monitored. The electrodes of a bispectral index (BIS) Vista monitor were placed on the patient's forehead. The mask for oxygen inhalation at 6 L/min was then applied. Anesthesia was induced with 2mg midazolam, 0.3ug/kg sufentanil, 2-3mg/kg propofol and 0.3mg/kg cisatracurium using ideal body weight. Patients were intubated using a video double-lumen endotracheal tube \[Disposable sterile double-lumen tracheal intubation, Nortier\] by a senior anesthesiologist. Following confirmation of the double-lumen tube (DLT) placement position, two-lung ventilation was started at a respiratory rate of 15 breaths per minute, with an inspiratory to expiratory (I: E) ratio of 1:2, tidal volume of 8 ml/kg, and an inspired oxygen fraction (FiO2) of 0.8. Remifentanil (0.05-0.3 ug/kg/min) and propofol (4-12 mg/kg/h) were continuously infused to maintain anesthesia while the levels of BIS fluctuated between 40 and 60. The DLT placement location was verified again as soon as the disinfection and draping process started, and one-lung ventilation was initiated. In this study, we used a disposable plastic membrane glove and chopped off the fingers to create a unidirectional valve device. Our prior clinical experiment showed that this device permits gas in the non-ventilated lung to exit during exhalation, while ambient air could not enter via the collapsed cut hole during inhalation. In the unidirectional valve group, as soon as disinfection and draping began, the lumen of the Y-connector to the non-ventilated lung was clamped and the unidirectional valve device was fastened to the bronchoscope port of the tracheal lumen to initial the one-lung ventilation. In the closed lumen group, as soon as disinfection and draping began, the lumen of the Y-connector to the non-ventilated lung was clamped, and the bronchoscope port of the tracheal lumen was sealed off from the atmosphere until pleural opening. When the pleura opened, the bronchoscope port opened to the air for 30 seconds before closing once more until the one-lung ventilation was completed. The tidal volume was adjusted to 6 ml/kg during OLV, and the respiratory rate was set to 15 breaths per minute with a I:E ratio of 1:2 and FiO2 of 0.8. Positive expiratory pressure was not applied in this trial. After pleural opening, the thoracoscopic surgery procedure was captured on video using an electronic equipment. The anesthesiologist, who was blind to the specific lung collapse technique, watched the recordings after surgery and used a visual analogue scale to assess the quality of lung collapse at various time points. Bronchial suction was employed to foster lung collapse of the non-ventilated lung if there was no collapse or partial collapse of the lung during the surgical procedure. The number and timing of bronchial suction should be documented in detail. After surgery, patients were transferred to the post-anesthesia care unit (PACU) for continued monitoring. Throughout their hospital stay, the patients were visited daily, and any postoperative pulmonary issues were recorded in time until the patients were released from the hospital.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
the unidirectional valve group
In the unidirectional valve group, as soon as disinfection and draping began, the lumen of the Y-connector to the non-ventilated lung was clamped and the unidirectional valve device was fastened to the bronchoscope port of the tracheal lumen to initial the one-lung ventilation.
unidirectional valve apparatus
In the unidirectional valve group, we attached the unidirectional valve device to the lumen's distal port when one-lung ventilation initiated.
the closed lumen group
In the closed lumen group, as soon as disinfection and draping began, the lumen of the Y-connector to the non-ventilated lung was clamped, and the bronchoscope port of the tracheal lumen was sealed off from the atmosphere until pleural opening. When the pleura opened, the bronchoscope port opened to the air for 30 seconds before closing once more until the one-lung ventilation was completed.
occluding the non-ventilated endobronchial lumen
In the closed operative lumen group, we closed the lumen's distal port of non-ventilated lung when one-lung ventilation initiated.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
unidirectional valve apparatus
In the unidirectional valve group, we attached the unidirectional valve device to the lumen's distal port when one-lung ventilation initiated.
occluding the non-ventilated endobronchial lumen
In the closed operative lumen group, we closed the lumen's distal port of non-ventilated lung when one-lung ventilation initiated.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) physical status I to III
* Patients scheduled to undergo video-associated thoracoscopic surgery requiring one-lung ventilation
Exclusion Criteria
1. anticipated difficult intubation
2. New York Heart Association (NYHA) heart failure class III/IV
3. body mass index≥35kg/m2
4. patients with abnormal expiratory recoil \[forced expiratory volume in 1s (FEV1) less than 70% of predicted values
5. chronic obstructive pulmonary disease (COPD) or severe asthma
6. prior thoracic surgery or radiotherapy
7. a history of pleural or interstitial disease
B - post-randomization
1. the discovery of pleural adhesions following pleural opening
2. a delay of more than 25 minutes between the onset of one-lung ventilation and chest opening
3. the duration between the onset of one-lung ventilation and chest opening less than 10 minutes
4. a switch to thoracotomy as the type of surgical procedure
5. he occurrence of significant adverse events during the operation, such as severe bleeding (more than 1500ml), fatal arrhythmia, respiratory arrest, or cardiac arrest
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sichuan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peng Liang,MD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peng Liang, PhD
Role: STUDY_DIRECTOR
West China Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West China Hospital
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023HXFH012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.